Rapport Therapeutics, Inc. (RAPP) insider trading
Rapport Therapeutics, Inc. insiders have made 7 open-market purchases worth $22.0M since Oct 21, 2026, by 7 different insiders. The latest: James Healy (Director) bought $20.4M, filed Oct 30, 2026, scored 72 out of 100. 6 buys in the last year came within ten days of another insider's: a cluster, one of the stronger patterns in the research.
Follow RAPP, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 30 Form 4 (opens sec.gov) |
James HealyDirector · 7 insiders buyingDirector · 7 insiders buying · Near 52-week low | +51% stake | 72 | $20.4M 969,480 at $21.00 |
waiting | waiting |
| Oct 23 Form 4 (opens sec.gov) |
Ramiro SanchezDirector · 6 insiders buyingDirector · 6 insiders buying · Near 52-week low | New position | 62 | $98k 3,600 at $27.35 |
waiting | waiting |
| Oct 22 Form 4 (opens sec.gov) |
Paul M. SilvaDirector · 5 insiders buyingDirector · 5 insiders buying · Near 52-week low | New position | 62 | $100k 3,680 at $27.07 |
−3.4% | waiting |
| Oct 22 Form 4 (opens sec.gov) |
Wendy B. YoungDirector · 4 insiders buyingDirector · 5 insiders buying · Near 52-week low | +40% stake | 58 | $100k 3,789 at $26.39 |
−3.4% | waiting |
| Oct 22 Form 4 (opens sec.gov) |
Steven M. PaulDirector · 3 insiders buyingDirector · 5 insiders buying · Near 52-week low | +86% stake | 69 | $974k 35,714 at $27.28 |
−3.4% | waiting |
| Oct 22 Form 4 (opens sec.gov) |
John MaraganoreDirector · 2 insiders buyingDirector · 2 insiders buying · Near 52-week low | New position | 56 | $249k 9,411 at $26.45 |
−3.4% | waiting |
| Oct 21 Form 4 (opens sec.gov) |
Troy A. IgnelziCFOCFO · Near 52-week low | +55% stake | 58 | $144k 5,500 at $26.10 |
−8.7% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −4.5% (0% up, 5 measured).
Insider sales
4 open-market sales on record
| Filed | Insider | Sold |
|---|---|---|
| Oct 23 Form 4 (opens sec.gov) |
Abraham CeesayCEO · planned (10b5-1) | $64k 2,210 at $29.16 · 0% of holdings |
| Oct 8 Form 4 (opens sec.gov) |
Abraham CeesayCEO · planned (10b5-1) | $143k 4,522 at $31.68 · 1% of holdings |
| Oct 1 Form 4 (opens sec.gov) |
Cheryl GaultCOO · planned (10b5-1) | $332k 10,000 at $33.19 · 7% of holdings |
| Sep 24 Form 4 (opens sec.gov) |
Abraham CeesayCEO · planned (10b5-1) | $87k 2,210 at $39.17 · 0% of holdings |
Most insider sales are planned in advance or made for personal reasons, so a sale says less than a buy.
Insiders who bought RAPP
- James Healy Director
- Ramiro Sanchez Director
- Paul M. Silva Director
- Wendy B. Young Director
- Steven M. Paul Director
- John Maraganore Director
- Troy A. Ignelzi CFO
Questions
Are insiders buying RAPP stock?
Yes. In the last 90 days, 7 open-market purchases were filed, worth $22.0M, against $626k of open-market sales.
Who bought RAPP stock most recently?
James Healy, Director, bought 969,480 shares for $20.4M (Form 4 (opens sec.gov), filed Oct 30, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Oct 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer